Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 718975, 9 pages
http://dx.doi.org/10.1155/2015/718975
Research Article

IL-10 and ARG-1 Concentrations in Bone Marrow and Peripheral Blood of Metastatic Neuroblastoma Patients Do Not Associate with Clinical Outcome

1Laboratorio di Oncologia IRCCS Istituto Giannina Gaslini, 16148 Genova, Italy
2Laboratorio di Bioterapia, IRCCS AOU San Martino-Istituto Nazionale per la Ricerca sul Cancro, 16132 Genova, Italy
3Laboratorio di Patologica Clinica IRCCS Istituto Giannina Gaslini, 16148 Genova, Italy
4U.O. Oncologia IRCCS Istituto Giannina Gaslini, 16148 Genova, Italy

Received 1 August 2014; Accepted 25 September 2014

Academic Editor: Marco Antonio Velasco-Velázquez

Copyright © 2015 Fabio Morandi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplemental Figure 1. Kaplan-Meyer plot of EFS (A) and OS (B) obtained by stratifying the 41 stage 4 NB patients according to mRNA expression levels of IL10, FOXP3, ARG1 and CD163 in BM samples above (dotted line) or below (continuous line) median values. Y-axes represent % of event-free or alive patients, respectively. X-axes represent time of survival (months).

Supplemental Figure 2. Kaplan-Meyer plot of EFS (A) and OS (B) obtained by stratifying the 41 stage 4 NB patients according to mRNA expression levels of IL10, FOXP3, ARG1 and CD163 in PB samples above (dotted line) or below (continuous line) median values. Y-axes represent % of event-free or alive patients, respectively. X-axes represent time of survival (months).

  1. Supplementary Figures